CVS Earnings Beat Estimates. The Stock Fell. - Barron'sSkip to Main ContentThis copy is for your personal, non-commercial use only. Distribution and use of this material are governed by our Subscriber Agreement and by copyright law. For non-personal use or to order multiple copies, please contact Dow Jones Reprints at 1-800-843-0008 or visit www.djreprints.com.# CVS Stock Falls After Earnings Beat. This Concern Remains.By [Adam Clark]ShareResize---ReprintsIn this article[CVS][8411]CVS shares have fallen sli ...

Core Insights - CVS Health reported stronger-than-expected fourth-quarter results, surpassing Wall Street estimates for both earnings and revenue, indicating progress in its multi-year turnaround strategy [1] Financial Performance - The company achieved significant financial results, with earnings and revenue exceeding analyst expectations, showcasing effective management and operational improvements [1] Strategic Direction - CVS Health is actively pursuing a multi-year turnaround plan, which is reflected in its recent performance and commitment to enhancing its business model [1]

Core Insights - CVS Health's latest results indicate stable sales and adjusted profits, with upward adjustments to forecasts, but the stock is considered "cheap but risky" due to profit quality and high debt levels [2][15]. Financial Performance - In Q3 2025, CVS reported revenue of approximately $103 billion, an 8% increase year-over-year, with all segments contributing to growth [3]. - The adjusted EPS was around $1.60, a significant rise from the previous year, leading management to increase the full-year 2025 adjusted EPS forecast to the mid-$6 range [5]. - A $5.7 billion charge related to the Health Care Delivery segment resulted in a net loss for the quarter, affecting reported profit figures [4]. Valuation Metrics - CVS trades at a low Price-to-Sales (P/S) ratio of about 0.2x compared to roughly 3x for the S&P 500, indicating undervaluation [12]. - The Price-to-Earnings (P/E) ratio is over 200x, primarily due to one-time charges, but falls into low double digits when based on future projections or adjusted earnings [8][9]. Profitability and Debt Concerns - CVS has managed annual sales growth of about 7-8% over the past three years, slightly better than the S&P 500 average, but profitability is currently weak with low operating profit margins [10][13]. - The company's total debt is in the low $80 billion range, with a debt-to-equity ratio in the mid-80% range, indicating a high level of debt compared to market value [13][11]. Investment Suitability - The stock is deemed suitable for investors willing to take risks, as it is undervalued but has weak overall financial health due to high debt and low profit margins [15][16]. - CVS is not considered a safe investment, having experienced significant declines during market corrections in the past [14][17].

CVS Health's stock was up about 4% at the market open on Tuesday after the company boosted its revenue and profit guidance for the year and detailed its full-year expectations for 2026. ...

About this content About Emily Jarvie Emily began her career as a political journalist for Australian Community Media in Hobart, Tasmania. After she relocated to Toronto, Canada, she reported on business, legal, and scientific developments in the emerging psychedelics sector before joining Proactive in 2022. She brings a strong journalism background with her work featured in newspapers, magazines, and digital publications across Australia, Europe, and North America, including The Examiner, The Advocate, ...

Core Insights - The event on December 4, 2025, will celebrate the transformation of the Prichard building in Huntington, highlighting completed residential spaces and future project phases aimed at community revitalization [1][2]. Company Involvement - CVS Health has invested over $17 million in the Prichard project, contributing to the development of affordable senior housing and reinforcing its commitment to community health [3]. - CVS Health's broader investment in affordable housing in West Virginia exceeds $21 million, resulting in the creation or preservation of over 800 affordable housing units [3]. Community Impact - The transformation of the Prichard building is seen as a collaborative effort that enhances community wellbeing and provides safe housing for seniors [4]. - The project reflects a commitment to preserving local history while fostering new opportunities for residents [3][4]. Event Details - The event is free and open to the public, encouraging media coverage and community engagement [4].

Core Insights - Proactive provides fast, accessible, and actionable business and finance news content to a global investment audience [2] - The company focuses on medium and small-cap markets while also covering blue-chip companies and broader investment stories [3] - Proactive's news team delivers insights across various sectors including biotech, mining, oil and gas, and emerging technologies [3] Technology Adoption - Proactive is committed to adopting technology to enhance workflows and content production [4] - The company utilizes automation and software tools, including generative AI, while ensuring all content is edited and authored by humans [5]

Financial Data and Key Metrics Changes - The company reported adjusted operating income of $3.5 billion and adjusted earnings per share (EPS) of $1.60 for the third quarter, with a 36% increase in adjusted operating income and a nearly 47% increase in adjusted EPS year-over-year [4][15] - Revenues reached nearly $103 billion, marking an 8% increase compared to the prior year quarter [15][24] - The full-year 2025 adjusted EPS guidance was raised to a range of $6.55 to $6.65, up from the previous range of $6.30 to $6.40 [4][24] Business Line Data and Key Metrics Changes - In the healthcare benefits segment, revenues were nearly $36 billion, up over 9% year-over-year, with a medical benefit ratio of 92.8%, a decrease of 240 basis points from the prior year [15][16] - The health services segment generated revenues of over $49 billion, an increase of over 11% year-over-year, although adjusted operating income decreased by 7% to approximately $2.1 billion [18][19] - The pharmacy and consumer wellness segment reported revenues of over $36 billion, a nearly 12% increase year-over-year, with same-store pharmacy sales growing nearly 17% [22][24] Market Data and Key Metrics Changes - The company ended the quarter with medical membership of approximately 26.7 million, flat sequentially but down approximately 445,000 members year-over-year [16] - The pharmacy market share grew to approximately 28.9%, reflecting strong operational performance and customer engagement [22][46] Company Strategy and Development Direction - The company is focused on becoming the most trusted healthcare company in America, emphasizing the importance of diversified business and strategic investments [4][12] - Aetna's performance is improving, with expectations of continued leadership in Medicare Advantage ratings [5][6] - The company is adapting its healthcare delivery strategy, including a reduction in the growth of Oak Street Health clinics, while maintaining a commitment to value-based care [7][21] Management's Comments on Operating Environment and Future Outlook - Management expressed a disciplined and cautious outlook for 2026, highlighting the importance of executing on commitments and adapting to market changes [5][14] - The company remains optimistic about the future, driven by strong performance across diversified business lines and strategic initiatives [13][30] Other Important Information - A goodwill impairment charge of approximately $5.7 billion was recorded in the healthcare delivery segment due to strategic changes in clinic growth expectations [7][20] - The company is actively working on recontracting efforts and improving financial performance in its healthcare delivery business [21][72] Q&A Session Summary Question: Comments on PBM side and future PBM economics - Management acknowledged headwinds in the PBM sector but emphasized the strength of a diversified company and the ongoing transition to a true cost model [32][34] - The company remains confident in delivering strong earnings and cash flow despite near-term challenges [34][41] Question: Drivers of confidence in PCW growth - Management highlighted strong execution, community pharmacy engagement, and the impact of the Rite Aid acquisition as key drivers for growth in the PCW segment [44][46] Question: Provider liabilities and impact on MBR - Management clarified that the 100 basis points of provider liabilities were related to historical matters and not expected to be a recurring issue [52][54] Question: Recontracting efforts at Oak Street - Management indicated that the focus is on ensuring sustainable agreements with payers and improving the path to profitability for Oak Street Health [71][72]

Core Insights - CVS Health experienced double-digit sales growth in its drugstores and pharmacy benefits management business, leading to better-than-expected third-quarter results [1] - The company raised its 2025 earnings forecast significantly above Wall Street estimates, despite incurring a nearly $6 billion charge related to its care delivery business [1][8] Sales and Revenue - CVS filled more prescriptions at drugstores, partly due to business from the defunct Rite Aid chain, with a 9% sales increase in its health insurance segment driven by improvements in Medicare and Medicaid coverage [2] - Total revenue grew almost 8% to $102.9 billion, surpassing analysts' expectations of $98.81 billion [6][7] Financial Performance - CVS reported a loss of nearly $4 billion in the third quarter, which included the $5.7 billion goodwill impairment charge for its care delivery business [6][3] - Adjusted earnings were reported at $1.60 per share, exceeding analysts' expectations of $1.37 per share [6][7] Care Delivery Business - The company recorded a $5.7 billion goodwill impairment charge related to its care delivery business, which includes Oak Street Health clinics acquired for approximately $10.6 billion [3] - CVS plans to close 16 underperforming clinics and reduce the number of new clinics it intends to open [3][5] Future Outlook - CVS Health now expects adjusted earnings for the year to range from $6.55 to $6.65 per share, an increase of 25 cents per share from its previous forecast [8]

Core Insights - Analysts expect the company to post earnings of $1.36 per share, which indicates a year-over-year increase of 24.8% [3] - Revenue is projected to reach $98.83 billion, reflecting a 3.6% increase compared to the previous period [3]